AirSculpt Technologies (NASDAQ:AIRS – Free Report) had its target price reduced by Lake Street Capital from $3.00 to $1.00 in a report published on Monday,Benzinga reports. They currently have a buy rating on the stock.
Other equities research analysts have also issued reports about the company. Wall Street Zen lowered AirSculpt Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, August 15th. Weiss Ratings restated a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, September 28th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $2.75.
Get Our Latest Stock Report on AirSculpt Technologies
AirSculpt Technologies Stock Up 4.5%
AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) last announced its earnings results on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). The business had revenue of $42.90 million for the quarter, compared to analysts’ expectations of $44.14 million. AirSculpt Technologies had a negative net margin of 6.36% and a negative return on equity of 9.43%.
Institutional Investors Weigh In On AirSculpt Technologies
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AIRS. Waverly Advisors LLC purchased a new stake in AirSculpt Technologies in the 2nd quarter valued at about $101,000. AXQ Capital LP purchased a new position in shares of AirSculpt Technologies during the second quarter worth approximately $46,000. Flputnam Investment Management Co. purchased a new position in shares of AirSculpt Technologies during the second quarter worth approximately $3,114,000. Hsbc Holdings PLC purchased a new position in shares of AirSculpt Technologies during the second quarter worth approximately $63,000. Finally, Manatuck Hill Partners LLC bought a new stake in shares of AirSculpt Technologies during the second quarter valued at approximately $450,000. Institutional investors own 91.54% of the company’s stock.
AirSculpt Technologies Company Profile
AirSculpt Technologies, Inc. operates a medical aesthetics business focused on body-contouring and cosmetic procedures. Through its AirSculpt brand, the company provides minimally invasive liposuction and fat-transfer treatments designed to remove unwanted fat and reshape areas of the body. Its services also include procedures such as skin tightening and other elective aesthetic treatments, with offerings varying by location and patient needs. AirSculpt markets its procedures directly to consumers and provides consultations, treatment planning and follow-up care through its network of company-operated centers.
See Also
- Five stocks we like better than AirSculpt Technologies
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
